Brief: NeoGenomics Q1 Revenue USD 187 Million Vs. IBES Estimate USD 184.5 Million
28/04/2026 21:05
Apr 28 (Reuters) - NeoGenomics Q1 operating expenses USD 99 million. Q1 adjusted EBITDA USD 9 million Q1 adjusted net income USD 1.4 million Q1 gross profit USD 81 million Q1 net income USD -17 million
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring